Results 271 to 280 of about 3,290,525 (388)

Long-Term Persistent Headache After SARS-CoV-2 Infection: A Follow-Up Population-Based Study. [PDF]

open access: yesEur J Neurol
Silva L   +14 more
europepmc   +1 more source

Post-varicella vaccination uveitis in a child with nephrotic syndrome receiving immunosuppressive treatment: a case report. [PDF]

open access: yesFront Pediatr
Andrade C   +6 more
europepmc   +1 more source

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner   +10 more
wiley   +1 more source

Germline genetic variants in young-onset sporadic pituitary macroadenomas: A multigene panel analysis. [PDF]

open access: yesJ Clin Transl Endocrinol
Gaspar LM   +10 more
europepmc   +1 more source

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper

open access: yesESC Heart Failure, EarlyView.
Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira   +26 more
wiley   +1 more source

Pruritic Maculopapular Eruption of a 4-month-old Baby: A Quiz. [PDF]

open access: yesActa Derm Venereol
Almeida-Silva G   +4 more
europepmc   +1 more source

EVOLUTION‐HF DEallEF: A non‐interventional study of patients with heart failure initiated on dapagliflozin: study design

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) is one of today's leading public health issues worldwide. The sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin recently received a label expansion. It is now approved for treatment of HF across the entire spectrum of ejection fraction (EF) in Germany. However, real‐world data are limited.
Matthias Paul   +7 more
wiley   +1 more source

Celebrating a decade of the HFA young community: Achievements and future directions by the HFA Young Committee

open access: yesESC Heart Failure, EarlyView.
Abstract The Heart Failure Association (HFA) Young initiative, established in 2014, welcomes all HFA members under 40 years of age, including physicians, scientists, nurses and allied health professionals. Its primary aim is to foster the growth of the next generation of heart failure (HF) specialists through a variety of educational and career ...
Mateusz Sokolski   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy